<akomaNtoso xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0 http://docs.oasis-open.org/legaldocml/akn-core/v1.0/os/part2-specs/schemas/akomantoso30.xsd" xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xmlns:html="http://www.w3.org/1999/xhtml" xmlns:akn4un="http://un.org/akn4un">
  <!--This is an unofficial copy for informational purposes only and prepared from the official electronic file-->
  <statement name="resolution">
    <meta>
      <identification source="#DGACM">
        <FRBRWork>
          <FRBRthis value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/!main/"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/"></FRBRuri>
          <FRBRdate date="2025-07-07" name="adoption"></FRBRdate>
          <FRBRauthor href="ga" as="author"></FRBRauthor>
          <FRBRcountry value="un"></FRBRcountry>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/eng@!main/"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/eng@/"></FRBRuri>
          <FRBRdate date="2025-07-09" name="publication"></FRBRdate>
          <FRBRauthor href="ga" as="issuer"></FRBRauthor>
          <FRBRlanguage language="eng"></FRBRlanguage>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/eng@/!main.xml"></FRBRthis>
          <FRBRuri value="/akn/un/statement/deliberation/unga-hrc/2025-07-07/59-7/eng@.xml"></FRBRuri>
          <FRBRdate date="2025-09-08" name="markup"></FRBRdate>
          <FRBRauthor href="DGACM" as="editor"></FRBRauthor>
        </FRBRManifestation>
      </identification>
      <classification source="DHLAUTH">
        <keyword value="RIGHT TO HEALTH" href="http://metadata.un.org/thesaurus/1005560" showAs="RIGHT TO HEALTH" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="PHARMACEUTICALS" href="http://metadata.un.org/thesaurus/1004870" showAs="PHARMACEUTICALS" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="VACCINES" href="http://metadata.un.org/thesaurus/1006845" showAs="VACCINES" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="MEDICAL SUPPLIES" href="http://metadata.un.org/thesaurus/1004020" showAs="MEDICAL SUPPLIES" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="HEALTH POLICY" href="http://metadata.un.org/thesaurus/1002838" showAs="HEALTH POLICY" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="EQUALITY" href="http://metadata.un.org/thesaurus/1002102" showAs="EQUALITY" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="RESEARCH AND DEVELOPMENT" href="http://metadata.un.org/thesaurus/1005499" showAs="RESEARCH AND DEVELOPMENT" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="TECHNOLOGY TRANSFER" href="http://metadata.un.org/thesaurus/1006431" showAs="TECHNOLOGY TRANSFER" dictionary="UNBIS Thesaurus"></keyword>
        <keyword value="SOCIALLY DISADVANTAGED PERSONS" href="http://metadata.un.org/thesaurus/1006005" showAs="SOCIALLY DISADVANTAGED PERSONS" dictionary="UNBIS Thesaurus"></keyword>
        <keyword refersTo="agenda" value="3" showAs="Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development." dictionary="A/HRC/59/1/Rev.1"></keyword>
      </classification>
      <workflow source="#un">
        <step date="2025-07-02" outcome="draftResolution" as="A/HRC/59/L.8" by="Algeria, Bangladesh, Brazil, China, Egypt, India, Indonesia, Samoa, Senegal, South Africa and Thailand" />
        <step date="0001-01-01" outcome="draftResolutionAdditionalSponsors" by="" />
        <step date="2025-07-09" outcome="recommendedForAdoption" by="" />
        <step date="2025-07-09" outcome="adopted" as="Adopted 32-0-15, 31st meeting" by="" />
      </workflow>
      <analysis source="#un">
        <parliamentary>
          <voting outcome="adoptedRecordedVote">
            <count value="32" refersTo="inFavour">
              <akn4un:voters>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/49486917-0912-4519-85a3-9db6c825987d">ALGERIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/c73a28a0-bba7-4de3-9674-0f06d0aac7a8">BANGLADESH</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/6f9c123e-4f9d-4a6a-8d06-7662b0741933">BENIN</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/6b4713e7-3a00-4d48-a15f-7ff6ea495d1f">BOLIVIA (PLURINATIONAL STATE OF)</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/8f2da5d0-fa10-46ef-a221-d036584a97e7">BRAZIL</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/05d47d83-cd3b-4824-b823-782edafcf308">BURUNDI</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/2ea1bb00-22aa-460a-ba5c-2a05169fc2f6">CHILE</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/f9584092-3401-4a9a-a43f-6697c61fcf33">CHINA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/165cc4b7-4208-4baa-98fd-921108e83888">COLOMBIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/186ccfb3-cac0-4ba4-a0ea-df0a624959a2">COSTA RICA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/473610d6-eb4c-4ea2-a0ea-7c45e6d50a3a">CÔTE D'IVOIRE</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/fcf098a7-56e9-43ce-aa3e-7ea50c956c8a">CUBA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/995fe3d3-51ff-42dd-904a-155373f208be">DEMOCRATIC REPUBLIC OF THE CONGO</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/16b4ddd5-fc12-4056-a10c-fc0953194825">DOMINICAN REPUBLIC</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/2203cfb4-b25b-4639-885c-1d58c8d3114f">ETHIOPIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/7221a14c-4c12-42d1-84bd-e23ec48117d9">GAMBIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/aa84bb56-adb8-412e-94c8-a152b96d9766">GHANA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/73d76131-a55c-43b4-8dcd-bfe9bdbc52e3">INDONESIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/12f4924a-61d7-48d0-8951-e9adc48863b8">KENYA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/b337dcf4-c984-4f33-9fec-4d4bd1568fe6">KUWAIT</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/9985b7c8-6ff2-4e1e-ae1d-e33b81d8ec80">KYRGYZSTAN</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/c357f8bb-2aac-43d9-b02b-ca2b729ab475">MALAWI</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/31a35e3f-5741-4c17-b067-2e771e3b5bbe">MALDIVES</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/9c5bd666-9a09-42e1-8f15-1d98411b1197">MARSHALL ISLANDS</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/86af548b-4937-46a5-892c-e2143400e530">MEXICO</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/0b101161-cf59-48fc-895f-d482226a5b03">MOROCCO</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/b5aec67e-3382-4cc2-bba1-d9e5188b149e">QATAR</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/5473bc2f-d634-4699-a8c2-84cb1fa7d434">REPUBLIC OF KOREA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/e3b4a626-fd77-4083-b30f-d6c1dca3a910">SOUTH AFRICA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/cf4c819e-b2ad-474d-81ce-1e47f9ce115d">SUDAN</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/0159ec12-b34f-4a0d-852a-359ede7b2de9">THAILAND</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/cc63aa1f-62b8-4edf-b7c8-03111fa66d89">VIET NAM</organization>
              </akn4un:voters>
            </count>
            <count value="15" refersTo="abstaining">
              <akn4un:voters>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/c2263f22-a4b7-48f0-abe8-f8fc08a9d3dd">ALBANIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/ad625fa0-7193-4eb2-9dab-7456b710e52a">BELGIUM</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/e6c182a4-1c59-4211-8d24-747e3501c6e0">BULGARIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/f0c694fb-1539-4fd6-bff1-710210911e61">CYPRUS</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/4275087d-4018-4082-899d-95f37efeda65">CZECHIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/956a3881-b5fe-406b-8177-9fe7d9b835af">FRANCE</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/999de5ba-5ff1-424c-8d44-b97c8f0dfbd1">GEORGIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/745bbc2a-fc50-4b94-bb96-2ff7ed380081">GERMANY</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/e1eabd31-bc07-4cbf-9bf9-cabde8b9cf8b">ICELAND</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/6bf9481b-2a49-475f-a0cb-eaa6544800ea">JAPAN</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/089a6443-0bba-4dd2-bc8d-a4888bb508b8">NETHERLANDS (KINGDOM OF THE)</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/1c98d616-3b6a-4d15-a7cb-f88c7f988b83">NORTH MACEDONIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/67e45b85-8dbb-4986-a38f-e53fe09104e7">ROMANIA</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/81bf68f1-1c05-4153-8964-bf5a1672fd0c">SPAIN</organization>
                <organization refersTo="memberState" GUID="https://unterm.un.org/unterm2/en/view/12258e51-56fe-43c6-9787-ed88fb50e1c1">SWITZERLAND</organization>
              </akn4un:voters>
            </count>
          </voting>
        </parliamentary>
      </analysis>
      <references source="#DGACM">
        <TLCOrganization eId="source" href="/akn/ontology/organization/un/DGACM" showAs="DGACM"></TLCOrganization>
        <TLCConcept eId="dateOfIssuance" href="/akn/ontology/concept/un/dateOfIssuance" showAs="Date of issuance"></TLCConcept>
        <TLCConcept eId="dateOfAdoption" href="/akn/ontology/concept/un/dateOfAdoption" showAs="Date of adoption"></TLCConcept>
        <TLCConcept eId="symbol" href="/akn/ontology/reference/un/symbol" showAs="Symbol"></TLCConcept>
        <TLCRole eId="publisher" href="/akn/ontology/role/un/publisher" showAs="Publisher"></TLCRole>
        <TLCRole eId="issuingBody" href="/akn/role/concept/un/issuingBody" showAs="Issuing body"></TLCRole>
        <TLCRole eId="subsidiaryBody" href="/akn/role/concept/un/subsidiaryBody" showAs="Subsidiary body"></TLCRole>
        <TLCRole eId="author" href="/akn/ontology/role/un/author" showAs="Author"></TLCRole>
        <TLCRole eId="editor" href="/akn/ontology/role/un/editor" showAs="Editor"></TLCRole>
        <TLCRole eId="distribution" href="/akn/ontology/concept/un/generalDistribution" showAs="General distribution"></TLCRole>
        <TLCOrganization eId="hrc" href="/akn/ontology/organization/un/generalAssembly/humanRightsCouncil" showAs="Human Rights Council"></TLCOrganization>
        <TLCTerm eId="resolutionTitle" href="/akn/ontology/reference/un/resolutionTitle" showAs="Resolution title"></TLCTerm>
        <TLCTerm eId="memberState" href="/akn/ontology/organization/un/memberState" showAs="Member State"></TLCTerm>
        <TLCTerm eId="inFavour" href="/akn/ontology/concept/un/voting/inFavour" showAs="In favour"></TLCTerm>
        <TLCTerm eId="against" href="/akn/ontology/concept/un/voting/against" showAs="Against"></TLCTerm>
        <TLCTerm eId="abstaining" href="/akn/ontology/concept/un/voting/abstaining" showAs="Abstaining"></TLCTerm>
        <TLCTerm eId="english" href="/akn/ontology/concept/un/language/english" showAs="English"></TLCTerm>
      </references>
      <presentation source="#un">
        <akn4un:footerFirstPage>
          <akn4un:footerFirstPageLeft>
            <akn4un:internalCode>
              <docketNumber refersTo="#publicationJobNumber"></docketNumber>
              <img alt="bar code" class="barCode" src=""></img>
            </akn4un:internalCode>
          </akn4un:footerFirstPageLeft>
          <akn4un:footerFirstPageRight>
            <img alt="Please recycle" class="image" src="./recylcleLogo.jpg"></img>
            <img alt="embedded QR code" class="qrCode" src=""></img>
          </akn4un:footerFirstPageRight>
        </akn4un:footerFirstPage>
      </presentation>
    </meta>
    <coverPage eId="coverPage_1">
      <p>
        <span refersTo="#publisher" class="upperLeft">
          <docAuthority refersTo="#publisher">United Nations</docAuthority>
        </span>
      </p>
      <p class="upperRight">
        <docNumber refersTo="#symbol">A/HRC/RES/59/7</docNumber>
      </p>
      <p class="upperLeft">
        <img src="logo-un.jpg"></img>
        <docAuthority refersTo="#issuingBody" class="rightBig">General Assembly</docAuthority>
      </p>
      <p>
        <docStatus refersTo="#generalDistribution" class="rightSmall">Distr.: General</docStatus>
      </p>
      <p>
        <docDate date="2025-07-09" class="rightSmall" refersTo="#dateOfIssuance">9 July 2025</docDate>
      </p>
      <p>
        <inline refersTo="#english" name="originalLanguage">Original: English</inline>
      </p>
      <p>
        <docAuthority refersTo="#subsidiaryBody">Human Rights Council</docAuthority>
      </p>
      <p>
        <session refersTo="#humanRightsCouncil" value="59" eId="coverPage_1__session_1">Fifty-ninth session</session>
      </p>
      <p>
        <event refersTo="#session">
          <date date="2025-06-16" refersTo="#startDate">16 June</date>
          <date date="2025-07-08" refersTo="#endDate">8 July 2025</date>
        </event>
      </p>
      <p>
        <inline title="3" name="agenda item">Agenda item 3</inline>
      </p>
      <p>
        <inline name="agenda item name">Promotion and protection of all human rights, civil, political, economic, social and cultural rights, including the right to development</inline>
      </p>
      <p>
        <docTitle>Resolution adopted by the Human Rights Council  on 7 July 2025</docTitle>
      </p>
    </coverPage>
    <preface>
      <p>
        <docNumber>59/7.</docNumber>
        <docTitle refersTo="#resolutionTitle">
          <span class="bold">Access to medicines, vaccines and other health products in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health</span>
        </docTitle>
      </p>
    </preface>
    <preamble>
      <formula name="enactingFormula" eId="formula_1">
        <p xml:space="preserve">
          <span class="italic">The Human Rights Council</span>,</p>
      </formula>
      <container name="Guided" eId="container_2">
        <p xml:space="preserve"> <span class="italic">Guided </span>by the purposes and principles of the Charter of the United Nations,</p>
      </container>
      <container name="Reaffirming" eId="container_3">
        <p xml:space="preserve"> <span class="italic">Reaffirming</span> the Universal Declaration of Human Rights,</p>
      </container>
      <container name="Reaffirming also" eId="container_4">
        <p xml:space="preserve"> <span class="italic">Reaffirming also</span> that the right of everyone to the enjoyment of the highest attainable standard of physical and mental health is a human right as reflected in, inter alia, the Universal Declaration of Human Rights, the International Covenant on Economic, Social and Cultural Rights and the Convention on the Rights of the Child and, with respect to non‑discrimination, in the International Convention on the Elimination of All Forms of Racial Discrimination, the Convention on the Elimination of All Forms of Discrimination against Women and the Convention on the Rights of Persons with Disabilities, and that the Constitution of the World Health Organization also recognizes the enjoyment of the highest attainable standard of health as a fundamental right of every human being, without distinction of race, religion, political belief, economic or social condition,</p>
      </container>
      <container name="Welcoming" eId="container_5">
        <p xml:space="preserve"> <span class="italic">Welcoming</span> the adoption by the World Health Organization of the Pandemic Agreement during the seventy-eighth World Health Assembly, which includes articles on research and development, sustainable and geographically diversified local production, transfer of technology and cooperation on related know-how for the production of pandemic–related health products, and the pathogen access and benefit-sharing system, and looking forward to a timely conclusion of negotiations led and driven by Member States on the annex to the Agreement on pathogen access and benefit-sharing,</p>
      </container>
      <container name="Noting" eId="container_6">
        <p xml:space="preserve"> <span class="italic">Noting</span> the establishment of a coalition for local and regional production, innovation and equitable access centred on voluntary cooperation in order to promote access to vaccines, therapeutics and diagnostics, and other health technologies for neglected diseases and persons in vulnerable situations,</p>
      </container>
      <container name="Recalling" eId="container_7">
        <p xml:space="preserve"> <span class="italic">Recalling</span> Human Rights Council resolution 50/13 of 7 July 2022 and all relevant previous resolutions and decisions on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health adopted by the Council, the General Assembly and the Commission on Human Rights, including Council resolutions 41/10 of 11 July 2019, 44/2 of 16 July 2020, 46/14 of 23 March 2021, 49/19 of 1 April 2022 and 49/25, also of 1 April 2022, in which the Council highlighted the need for ensuring equitable, affordable, timely and universal access for all countries to vaccines in response to the coronavirus disease (COVID‑19) pandemic and for promoting and protecting economic, social and cultural rights within the context of addressing inequalities in the recovery from the pandemic,</p>
      </container>
      <container name="Recalling also" eId="container_8">
        <p xml:space="preserve"> <span class="italic">Recalling also</span> General Assembly resolution 74/306 of 11 September 2020, in which the Assembly recognized that the COVID‑19 pandemic was one of the greatest global challenges in the history of the United Nations, and noting with deep concern its negative impact on the enjoyment of human rights and the exacerbation of poverty and hunger, as well the exacerbation of economic and social inequalities within and among countries, which has reversed hard-won development gains and hampered progress towards achieving the 2030 Agenda for Sustainable Development and all its Goals and targets,</p>
      </container>
      <container name="Acknowledging" eId="container_9">
        <p xml:space="preserve"> <span class="italic">Acknowledging </span>that persons in vulnerable situations, such as children, women, older persons, migrants, persons with disabilities, persons in the informal economy, Indigenous Peoples as well as local communities, are disproportionately affected by pandemics,</p>
      </container>
      <container name="Recalling" eId="container_10">
        <p xml:space="preserve"> <span class="italic">Recalling </span>General Assembly resolution 79/287 of 29 April 2025, in which the Assembly expressed deep concern about the uneven access of developing countries to safe, quality, efficacious, effective, accessible and affordable vaccines against COVID‑19, and emphasized the need to enhance the capacities of developing countries to achieve universal health coverage and have equitable access to vaccines and health technologies and means to respond to and recover from the COVID‑19 and other pandemics,</p>
      </container>
      <container name="Noting with extreme concern" eId="container_11">
        <p xml:space="preserve"> <span class="italic">Noting with extreme concern</span> that, for millions of people throughout the world, the full and equal enjoyment of the right to the highest attainable standard of physical and mental health still remains a distant goal,</p>
      </container>
    </preamble>
    <mainBody>
      <paragraph eId="para_12" class="SingleTxtG">
        <content eId="para_12__content">
          <p xml:space="preserve"> <span class="italic">Extremely concerned</span> that, according to the World Health Organization, worldwide, tuberculosis is the tenth leading cause of death and has probably returned to being the world’s leading cause of death from a single infectious agent,</p>
        </content>
      </paragraph>
      <paragraph eId="para_13" class="SingleTxtG">
        <content eId="para_13__content">
          <p xml:space="preserve"> <span class="italic">Extremely concerned also</span> that HIV/AIDS remains one of the world’s most significant public health challenges, particularly in developing countries,</p>
        </content>
      </paragraph>
    </mainBody>
    <preamble>
      <container name="Recalling" eId="container_14">
        <p xml:space="preserve"> <span class="italic">Recalling </span>General Assembly resolution 73/3 of 10 October 2018, in which the Assembly adopted the political declaration on the fight against tuberculosis, which called for and committed to the promotion of access to affordable medicines, including generics, and for scaling up access to affordable tuberculosis treatment, and noting with concern the rising number of cases caused by the COVID‑19 pandemic,</p>
      </container>
      <container name="Concerned" eId="container_15">
        <p xml:space="preserve"> <span class="italic">Concerned</span> that tropical diseases impose a devastating human, social and economic burden on more than 1 billion people, predominantly in neglected tropical and subtropical areas and among those in the most vulnerable situations,</p>
      </container>
      <container name="Concerned also" eId="container_16">
        <p xml:space="preserve"> <span class="italic">Concerned also</span> that non‑communicable diseases kill 41 million people every year, equivalent to 71 per cent of all deaths globally, mostly in developing countries, and that people living with non‑communicable diseases are at a higher risk of severe illness and death due to COVID‑19 and other infectious diseases,</p>
      </container>
      <container name="Stressing" eId="container_17">
        <p xml:space="preserve"> <span class="italic">Stressing</span> that the full and equal enjoyment of the right to the highest attainable standard of physical and mental health implies sustained efforts to solve current health challenges particularly affecting those in the most vulnerable situations, as well as better prevention, preparedness and responses to future health emergencies, including pandemics,</p>
      </container>
      <container name="Acknowledging" eId="container_18">
        <p xml:space="preserve"> <span class="italic">Acknowledging </span>that achieving universal health coverage, as mentioned in Sustainable Development Goal 3, implies focusing on improving essential health services and health systems to better than pre‑pandemic levels and expanding access to quality health services and through primary healthcare for all, including for those in vulnerable situations, especially in developing countries,</p>
      </container>
      <container name="Taking note" eId="container_19">
        <p xml:space="preserve"> <span class="italic">Taking note </span>of the Rio de Janeiro Declaration by the Group of 20 Health Ministers, in which they prioritized a discussion on the strengthening of pandemic prevention, preparedness and response, focusing on enhancing local and regional production of medicines, vaccines, diagnostics and strategic health supplies, digital health, climate change and health, and advancing a One Health approach, with health equity as a cross-cutting theme,</p>
      </container>
      <container name="Recalling" eId="container_20">
        <p xml:space="preserve"> <span class="italic">Recalling</span> the Declaration on the Right to Development, which, inter alia, established that States should take, at the national level, all measures necessary for the realization of the right to development and should ensure, inter alia, equality of opportunity for all in their access to basic resources, such as health services,</p>
      </container>
      <container name="Reaffirming" eId="container_21">
        <p xml:space="preserve"> <span class="italic">Reaffirming</span> General Assembly resolution 70/1 of 27 September 2015, entitled “Transforming our world: the 2030 Agenda for Sustainable Development”, in which the Assembly adopted the outcome document of the United Nations summit for the adoption of the post-2015 development agenda, recognizing that eradicating poverty in all its forms and dimensions, including extreme poverty, is among the greatest global challenges and an indispensable requirement for sustainable development and envisaging a world free of poverty, hunger, disease and want, a world of universal respect for human rights and human dignity that includes equitable and universal access to healthcare and social protection, and where physical, mental and social well-being are assured,</p>
      </container>
      <container name="Recalling" eId="container_22">
        <p xml:space="preserve"> <span class="italic">Recalling</span> the Sustainable Development Goals, including, inter alia, Goal 3 on ensuring healthy lives and promoting well-being for all at all ages, and its specific and interlinked targets, such as target 3.8 on achieving universal health coverage, which also implies a focus on improving essential health services and health systems to better than pre‑pandemic levels, expanding access to quality health services and primary healthcare for all, including for those in vulnerable situations, especially in developing countries; Goal 3 also includes financial risk protection, access to quality essential healthcare services and access to safe, effective, quality and affordable essential medicines and vaccines for all; other health-related Goals and targets, and Goal 17 on strengthening the means of implementation and revitalizing the Global Partnership for Sustainable Development, and its specific and interlinked targets, particularly target 17.2, which states that developed countries should implement fully their official development assistance commitments, in addition to the guiding principle of the 2030 Agenda to leave no one behind,</p>
      </container>
      <container name="Concerned" eId="container_23">
        <p xml:space="preserve"> <span class="italic">Concerned </span>about the lack of data reported by countries under Sustainable Development Goal indicator 3.b.3, measuring the proportion of health facilities that have a core set of relevant essential medicines that are available and affordable on a sustainable basis, which serves as a global metric to measure and monitor progress on access to medicines and could be subject to deletion from the Global Indicator Framework for the Sustainable Development Goals and targets of the 2030 Agenda owing to data coverage of less than 30 per cent of countries,</p>
      </container>
      <container name="Acknowledging" eId="container_24">
        <p xml:space="preserve"> <span class="italic">Acknowledging</span> the need to address gaps in preventing, preparing for and responding to health emergencies, including in the development and distribution of, and unhindered, timely and equitable access to, medical countermeasures, such as vaccines, therapeutics and diagnostics, as well as to strengthen health systems and their resilience with a view to achieving universal healthcare,</p>
      </container>
      <container name="Recognizing" eId="container_25">
        <p xml:space="preserve"> <span class="italic">Recognizing </span>the need to tackle health inequities and inequalities within and among countries through political commitment, international cooperation and policies, including those that address the social, economic and environmental determinants of health, and the necessity to avoid any obstacles that are inconsistent with international law, including the Charter, that prevent the supply, distribution or procurement of any medical goods, including medications and medical equipment,</p>
      </container>
      <container name="Noting" eId="container_26">
        <p xml:space="preserve"> <span class="italic">Noting </span>the continued contributions of the Office of the United Nations High Commissioner for Human Rights, including the report submitted to the Human Rights Council at its fifty-second session pursuant to resolution 49/25 on equitable access to COVID‑19 vaccines;<authorialNote marker="2" placement="bottom" eId="authorialNote_2"><p xml:space="preserve">	 	A/HRC/52/56.</p></authorialNote> the convening of expert workshops in 2023, 2024 and 2025, pursuant to Council resolution 50/13, on good practices, key challenges and new developments in access to health products, and the comprehensive report on access to medicines, vaccines and other health products in the context of the right to the highest attainable standard of physical and mental health, including new developments, submitted to the Council at its present session;<authorialNote marker="3" placement="bottom" eId="authorialNote_3"><p xml:space="preserve">	 	A/HRC/59/29.</p></authorialNote> the submission of a compendium of good practices<authorialNote marker="4" placement="bottom" eId="authorialNote_4"><p xml:space="preserve">	 	A/HRC/53/50.</p></authorialNote> and an analytical study on key challenges<authorialNote marker="5" placement="bottom" eId="authorialNote_5"><p xml:space="preserve">	 	A/HRC/56/28.</p></authorialNote> to the Council at its fifty-third and fifty-sixth sessions respectively; and a report on challenges arising from the current pharmaceutical innovation system, submitted to the Economic and Social Council in 2023,<authorialNote marker="6" placement="bottom" eId="authorialNote_6"><p xml:space="preserve">		E/2023/74.</p></authorialNote></p>
      </container>
      <container name="Recalling" eId="container_27">
        <p xml:space="preserve"> <span class="italic">Recalling</span> the report of the High-level Panel on Access to Medicines, convened by the Secretary-General, which made proposals on how to address policy incoherence in public health, trade, the justifiable rights of inventors, and human rights,</p>
      </container>
      <container name="Recalling also" eId="container_28">
        <p xml:space="preserve"> <span class="italic">Recalling also</span> General Assembly resolution 79/2 of 7 October 2024, in which the Assembly adopted the political declaration of the high-level meeting on antimicrobial resistance, wherein Heads of State and Government and other representatives recognized that the affordability of and equitable access to existing and new antimicrobial medicines, vaccines and diagnostics should be a global priority and should take into account the needs of all countries,</p>
      </container>
      <container name="Recalling further" eId="container_29">
        <p xml:space="preserve"> <span class="italic">Recalling further </span>General Assembly resolutions 74/2 of 10 October 2019 and 78/4 of 5 October 2023, in which the Assembly adopted the political declarations of the high-level meetings on universal health coverage, wherein Heads of State and Government and other representatives underlined that the affordability of and access to existing and new antimicrobial medicines, vaccines and diagnostics should be addressed through cooperation at the national, regional and global levels,</p>
      </container>
      <container name="Reaffirming" eId="container_30">
        <p xml:space="preserve"> <span class="italic">Reaffirming</span> the importance of the full implementation of the Global Strategy and the Plan of Action on Public Health, Innovation and Intellectual Property, in World Health Assembly resolutions WHA61.21 of 24 May 2008 and WHA62.16 of 22 May 2009 and decision WHA71(9) of 25 May 2018, which aims to promote new thinking on innovation and access to medicines and to secure an enhanced and sustainable basis for needs-driven essential health research and development relevant to diseases that disproportionately affect developing countries, and welcoming its extension, by resolution WHA75.14 of 28 May 2022, until 2030,</p>
      </container>
      <container name="Noting" eId="container_31">
        <p xml:space="preserve"> <span class="italic">Noting </span>the adoption of the Declaration on Future Generations,<authorialNote marker="7" placement="bottom" eId="authorialNote_7"><p xml:space="preserve">	 	General Assembly resolution 79/1, annex II.</p></authorialNote> wherein Heads of State and Government reaffirmed their commitment to protect the right to the enjoyment of the highest attainable standard of physical and mental health through universal health coverage and strengthened and resilient health systems, as well as equitable access to safe, affordable, effective and quality medicines, vaccines, therapeutics and other health products, to ensure healthy lives and promote well-being for present and future generations,</p>
      </container>
      <container name="Taking note" eId="container_32">
        <p xml:space="preserve"> <span class="italic">Taking note </span>of resolution WHA77.17 of 1 June 2024, adopted by the World Health Assembly at its seventy-seventh session, amending the International Health Regulations, and included measures to remove barriers to timely and equitable access to health products in the context of public health emergencies,</p>
      </container>
      <container name="Reaffirming" eId="container_33">
        <p xml:space="preserve"> <span class="italic">Reaffirming</span> the importance of improving the transparency of markets, costs and supply chains for medicines, vaccines and other health products across the whole value chain, and taking into consideration resolution WHA72.8 of 28 May 2019, adopted by the World Health Assembly at its seventy-second session,</p>
      </container>
      <container name="Recalling" eId="container_34">
        <p xml:space="preserve"> <span class="italic">Recalling</span> decision WHA73(9) of 3 August 2020, adopted by the World Health Assembly at its seventy-third session, in which the Assembly endorses the Immunization Agenda 2030, which envisions a world where everyone, everywhere and at every age fully benefits from vaccines for good health and well-being,</p>
      </container>
      <container name="Recalling also" eId="container_35">
        <p xml:space="preserve"> <span class="italic">Recalling also</span> resolution WHA74.8 of 31 May 2021, adopted by the World Health Assembly at its seventy-fourth session, on the highest attainable standard of health for persons with disabilities, in which the Assembly recognized the unique vulnerabilities of those who may be living in care and congregated living settings in times of public health emergencies,</p>
      </container>
      <container name="Seriously concerned" eId="container_36">
        <p xml:space="preserve"> <span class="italic">Seriously concerned</span> about the high prices of some health products and the inequitable access within and among States, as well as the financial hardships associated with high prices, which continue to impede progress towards achieving universal health coverage for all,</p>
      </container>
      <container name="Seriously concerned also" eId="container_37">
        <p xml:space="preserve"> <span class="italic">Seriously concerned also </span>that the supply of health products and technologies is dependent on manufacturing facilities concentrated in few countries and that the lack of adequate infrastructure and logistics expertise to store, distribute and deliver diagnostics, medicines, vaccines and other health products and technologies, particularly in developing countries, among other factors, hampers efforts to achieve diagnosis, treatment and vaccination targets for several diseases, at the right time, safely and efficiently, especially in the context of health emergencies,</p>
      </container>
      <container name="Recalling" eId="container_38">
        <p xml:space="preserve"> <span class="italic">Recalling</span> the Declaration on Primary Health Care, adopted in October 2018 in Astana, which recognized the need to address the inefficiencies and inequities that expose people to financial hardship resulting from their use of healthcare services by ensuring better allocation of resources for health and adequate financing of primary healthcare, and to work towards the financial sustainability, efficiency and resilience of national health systems, appropriately allocating resources to primary healthcare based on the national context,</p>
      </container>
      <container name="Concerned" eId="container_39">
        <p xml:space="preserve"> <span class="italic">Concerned </span>about the exacerbation of poverty in developing countries, with its disproportionate impact on women and girls and people of African descent, and about the interrelatedness between poverty and other social and economic determinants of health and the realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, in particular the fact that ill health can be both a cause and a consequence of poverty,</p>
      </container>
      <container name="Recognizing" eId="container_40">
        <p xml:space="preserve"> <span class="italic">Recognizing</span> the interconnectedness between social determinants of health and the persistent burden of some preventable diseases and that socially determined diseases also disproportionately impact vulnerable populations, especially those living in conditions of poverty, and entrenched inequalities,</p>
      </container>
      <container name="Recognizing also" eId="container_41">
        <p xml:space="preserve"> <span class="italic">Recognizing also </span>that universal health coverage implies that all people, everywhere, have access without discrimination to nationally determined sets of needed promotive, preventive, curative, palliative and rehabilitative essential healthcare services, and essential, safe, affordable, effective and quality medicines and vaccines, diagnostics and health technologies, including assistive technologies, while ensuring that the use of these services does not expose users to financial hardship, with special emphasis on the poor and vulnerable segments of the population,</p>
      </container>
      <container name="Recognizing further" eId="container_42">
        <p xml:space="preserve"> <span class="italic">Recognizing further </span>the need for States, in cooperation with regional and international organizations and civil society, including non‑governmental organizations, philanthropic foundations, academic and research institutions and the private sector, involved at all stages of the pharmaceuticals value chain, including research and development, manufacture, distribution and supply of pharmaceutical products, to create favourable conditions at the national, regional and international levels to ensure the full and equal enjoyment of the right of everyone to the highest attainable standard of physical and mental health,</p>
      </container>
      <container name="Deeply concerned" eId="container_43">
        <p xml:space="preserve"> <span class="italic">Deeply concerned</span> about the loss of lives and livelihoods and the disruption to economies and societies caused by the COVID‑19 pandemic, and its negative impact on the enjoyment of human rights around the world, particularly for women and girls, and recognizing that the COVID‑19 pandemic highlighted the critical need to prevent and prepare for potential disruptions of the supply chain for essential medicines and other health technologies, including through the strengthening of local production, and therefore welcoming resolution WHA74.6 of 31 May 2021, adopted by the World Health Assembly at its seventy-fourth session, on strengthening local production of medicines and other health technologies to improve access,</p>
      </container>
      <container name="Recalling" eId="container_44">
        <p xml:space="preserve"> <span class="italic">Recalling</span> that the Doha Ministerial Declaration on the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and Public Health confirms that the Agreement does not and should not prevent members of the World Trade Organization from taking measures to protect public health, and that the Declaration, accordingly, while reiterating the commitment to the Agreement, affirms that it can and should be interpreted and implemented in a manner supportive of the rights of members of the Organization to protect public health and, in particular, to promote access to medicines for all, and recognizes in this connection the right of members of the Organization to use to the full the provisions of the above-mentioned Agreement, which provide flexibility for this purpose, in accordance with the World Trade Organization ministerial decision of 17 June 2022 on the TRIPS Agreement,</p>
      </container>
      <container name="Acknowledging" eId="container_45">
        <p xml:space="preserve"> <span class="italic">Acknowledging</span> the entry into force of the protocol amending the TRIPS Agreement, which adapts the rules of the global trading system to the public health needs of people in low- and middle-income countries, thus contributing to the realization of the right to the enjoyment of the highest attainable standard of physical and mental health, particularly in poorer populations,</p>
      </container>
      <container name="Welcoming" eId="container_46">
        <p xml:space="preserve"> <span class="italic">Welcoming</span> the Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge, adopted by the World Intellectual Property Organization on 24 May 2024,</p>
      </container>
      <container name="Recognizing" eId="container_47">
        <p xml:space="preserve"> <span class="italic">Recognizing</span> the importance of creating a conducive environment that attracts and supports private investment, entrepreneurship and corporate social responsibility, including an efficient, adequate, balanced and effective intellectual property framework, while encouraging access to science and technology by developing countries and recognizing the vital role that science, technology and innovation, including environmentally sound technologies, can play in development and facilitating efforts to address global challenges,</p>
      </container>
      <container name="Regretting" eId="container_48">
        <p xml:space="preserve"> <span class="italic">Regretting</span> the high number of people still without access to affordable, safe, effective and quality medicines and vaccines, underscoring that improving such access could save millions of lives every year, and noting with deep concern that, globally, 2 billion people have no access to the medicines they need, while recognizing that the lack of access to medicines, vaccines and other health products, as well as access to immunization as a global public good, is a challenge that affects people not only in developing countries but also in developed countries, even though the disease burden is disproportionately high in developing countries,</p>
      </container>
      <container name="Concerned" eId="container_49">
        <p xml:space="preserve"> <span class="italic">Concerned</span> at the lack of access to quality, safe, effective and affordable medicines for children in appropriate dosage forms, and at problems in the rational use of children’s medicines in many countries, and that, globally, children aged under 5 years still do not have secure access to medicines for the treatment of communicable and non‑communicable diseases, including rare diseases,</p>
      </container>
      <container name="Concerned also" eId="container_50">
        <p xml:space="preserve"> <span class="italic">Concerned also</span> that, according to the World Health Organization, 14.5 million children globally have missed out on all vaccination, and that immunization levels have not recovered to the levels recorded prior to the COVID‑19 pandemic,</p>
      </container>
      <container name="Concerned further" eId="container_51">
        <p xml:space="preserve"> <span class="italic">Concerned further </span>that the increasing incidence of non‑communicable diseases constitutes a heavy burden on societies, with serious health, social and economic consequences, which represent a leading threat to human health and development, and recognizing the urgent need to improve accessibility to safe, affordable, effective and quality medicines and technologies to diagnose, treat and control non‑communicable diseases, to strengthen viable financing options and to promote the use of affordable medicines, including generics, as well as improved access to preventive, curative, palliative and rehabilitative services, particularly at the community level,</p>
      </container>
      <container name="Recognizing" eId="container_52">
        <p xml:space="preserve"> <span class="italic">Recognizing</span> the need to appropriately address challenges, gaps, market failures and opportunities regarding the research and development of health technologies, availability and affordability to diagnose and treat, inter alia, rare and neglected diseases, as well as infectious diseases, and to respond decisively to the growth of emerging challenges, such as antimicrobial resistance and pathogens with pandemic potential, among others, with a view to adequately addressing public health needs and protecting, respecting and fulfilling human rights, and taking into account the necessity to promote frameworks that meet public health needs, while adequately rewarding innovation,</p>
      </container>
      <container name="Considering" eId="container_53">
        <p xml:space="preserve"> <span class="italic">Considering</span> the report by the Director-General of the World Health Organization on cancer medicines, which, pursuant to resolution WHA70.12 of 31 May 2017, examined the impact of pricing approaches, including transparency, on the availability and affordability of medicines for the prevention and treatment of cancer, and a possible update of the study,</p>
      </container>
      <container name="Recognizing with appreciation" eId="container_54">
        <p xml:space="preserve"> <span class="italic">Recognizing with appreciation</span> the introduction of new pharmaceutical products made possible through investment in innovation for cancer treatment in recent years, while noting with great concern the increasing cost to health systems and patients, and emphasizing the importance of addressing barriers in access to safe, quality, effective and affordable medicines, medical products and appropriate technology for cancer prevention, detection, screening diagnosis and treatment, including surgery,</p>
      </container>
      <container name="Expressing deep concern" eId="container_55">
        <p xml:space="preserve"> <span class="italic">Expressing deep concern</span> at outbreaks of highly infectious pathogens with pandemic potential, which demonstrate the potential vulnerability of populations to them, and in this context reaffirming and underscoring the importance of research into and the development of new and innovative medicines, vaccines and other health products, and of ensuring access to safe, affordable, effective and quality medicines, vaccines and all other health products to all, including new and innovative medicines, as well as the importance of access to immunization as a global public good, and of building and/or strengthening health system capacities, including primary healthcare, for preventing, preparing for, detecting and responding in a timely manner to outbreaks, epidemics, pandemics and other health emergencies,</p>
      </container>
      <container name="Expressing deep concern also" eId="container_56">
        <p xml:space="preserve"> <span class="italic">Expressing deep concern also</span> at the particular challenge of access to medicines, vaccines and other health products in situations of conflict, including situations of foreign occupation, and condemning the increase in attacks targeting medical facilities and personnel, </p>
      </container>
      <container name="Realizing" eId="container_57">
        <p xml:space="preserve"> <span class="italic">Realizing</span> that, during the time of global pandemics and other health emergencies, the fulfilment of the right to the highest attainable standard of physical and mental health should be guided by a strong spirit of solidarity, in particular solidarity with the poorest and with people in vulnerable situations,</p>
      </container>
      <container name="Recognizing" eId="container_58">
        <p xml:space="preserve"> <span class="italic">Recognizing</span> the critical role of whole-of-government and whole-of-society approaches at the national and community levels through broad social participation, and recognizing also the value and diversity of the culture and traditional knowledge of Indigenous Peoples as well as local communities, including traditional medicine, in strengthening pandemic prevention, preparedness, response and health systems recovery,</p>
      </container>
    </preamble>
    <mainBody>
      <paragraph eId="para_59" class="SingleTxtG">
        <num>1.</num>
        <content eId="para_59__content">
          <p xml:space="preserve"> <span class="italic">	Recognizes</span> that timely, equitable and unhindered access to safe, affordable, effective and quality medicines, vaccines, diagnostics and therapeutics and other health products and technologies is one of the fundamental elements for the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health and the correspondent objectives of universal health coverage and health for all, without discrimination, with special attention to reaching those furthest behind first;</p>
        </content>
      </paragraph>
      <paragraph eId="para_60" class="SingleTxtG">
        <num>2.</num>
        <content eId="para_60__content">
          <p xml:space="preserve"> 	<span class="italic">Stresses</span> the responsibility of States to ensure timely, equitable and unhindered access for all, without discrimination, to safe, affordable, effective and quality medicines, vaccines, diagnostics and therapeutics, and other health products and technologies, as well as access to immunization as a global public good;</p>
        </content>
      </paragraph>
      <paragraph eId="para_62" class="SingleTxtG">
        <num>3.</num>
        <content eId="para_62__content">
          <p xml:space="preserve"> 	<span class="italic">Calls upon</span> States to promote timely, equitable and unhindered access to safe, effective, quality and affordable medicines, vaccines, diagnostics and therapeutics, and other health products and technologies, for all, including through the full use of the provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which provide flexibility for that purpose, while recognizing that the protection of intellectual property is important for the development of new and innovative medicines and vaccines, and the concerns about its effects on prices and public health;</p>
        </content>
      </paragraph>
      <paragraph eId="para_65" class="SingleTxtG">
        <num>4.</num>
        <content eId="para_65__content">
          <p xml:space="preserve"> 	<span class="italic">Also calls upon</span> States to take steps to implement policies and plans to promote access to comprehensive and cost-effective prevention, treatment and care for the integrated management of non‑communicable diseases, including, inter alia, increased access to affordable, safe, effective and quality medicines, vaccines and diagnostics and other health products, including through the full use of TRIPS Agreement provisions and flexibilities;</p>
        </content>
      </paragraph>
      <paragraph eId="para_69" class="SingleTxtG">
        <num>5.</num>
        <content eId="para_69__content">
          <p xml:space="preserve"> 	<span class="italic">Reiterates</span> the call upon States to continue to collaborate, as appropriate, on models and approaches that support the delinkage of the cost of new research and development from the prices of medicines, vaccines and diagnostics for diseases that predominantly affect developing countries, including emerging and neglected tropical diseases, so as to ensure their sustained accessibility, affordability and availability and to ensure access to treatment for all those in need;</p>
        </content>
      </paragraph>
      <paragraph eId="para_74" class="SingleTxtG">
        <num>6.</num>
        <list eId="para_74_list">
          <intro eId="para_74_list_intro">
            <p xml:space="preserve"> 	<span class="italic">Urges </span>States and all relevant stakeholders, in order to ensure timely, equitable and unhindered access for all persons to safe, affordable, effective and quality medicines, vaccines, diagnostics and therapeutics, and other health products and technologies with a view to advancing the realization of the Sustainable Development Goals:</p>
          </intro>
          <point eId="para_74_list_point_a">
            <num>(a)</num>
            <content eId="para_74_list_point_a_content">
              <p xml:space="preserve"> 	To promote research and capacity-building initiatives, and to enhance international cooperation on and access to science, innovation, technologies, technical assistance and knowledge-sharing, including by pooling initiatives, while appreciating the substantive efforts many States have already made to this end;</p>
            </content>
          </point>
          <point eId="para_74_list_point_b">
            <num>(b)</num>
            <content eId="para_74_list_point_b_content">
              <p xml:space="preserve"> 	To take all measures necessary to strengthen regional and local production by promoting innovative modalities of global partnerships and technology transfers, as mutually agreed, and to facilitate trade in medicines, vaccines and other health products;</p>
            </content>
          </point>
          <point eId="para_74_list_point_c">
            <num>(c)</num>
            <content eId="para_74_list_point_c_content">
              <p xml:space="preserve"> 	To share data and results in accordance with internationally agreed principles, including the sharing of pathogens, samples and genetic sequencing data, and ensure the fair and equitable sharing of benefits that arise from their utilization, in accordance with international access and benefit-sharing instruments;</p>
            </content>
          </point>
          <point eId="para_74_list_point_d">
            <num>(d)</num>
            <content eId="para_74_list_point_d_content">
              <p xml:space="preserve"> 	To promote the transfer of technology and know-how as mutually agreed, and to encourage research, innovation and commitment, where possible, to voluntary licensing in all agreements in which public funding has been invested in research and development;</p>
            </content>
          </point>
          <point eId="para_74_list_point_e">
            <num>(e)</num>
            <content eId="para_74_list_point_e_content">
              <p xml:space="preserve"> 	To assist in efforts to build capacity through training and financial support for developing countries to produce health technologies, including mRNA vaccine technology;</p>
            </content>
          </point>
          <point eId="para_74_list_point_f">
            <num>(f)</num>
            <content eId="para_74_list_point_f_content">
              <p xml:space="preserve"> 	To explore ways to promote equitable access and fair distribution of health products, including the possible establishment of a global end-to-end platform;</p>
            </content>
          </point>
          <point eId="para_74_list_point_g">
            <num>(g)</num>
            <content eId="para_74_list_point_g_content">
              <p xml:space="preserve"> 	To advance the health and care workforce investment agenda, with a special focus on the primary healthcare workforce and employment of women at all levels;</p>
            </content>
          </point>
          <point eId="para_74_list_point_h">
            <num>(h)</num>
            <content eId="para_74_list_point_h_content">
              <p xml:space="preserve"> 	To take measures to ensure accessible and affordable access to healthcare systems for persons with disabilities;</p>
            </content>
          </point>
        </list>
      </paragraph>
      <paragraph eId="para_80" class="SingleTxtG">
        <num>7.</num>
        <content eId="para_80__content">
          <p xml:space="preserve"> 	<span class="italic">Calls upon</span> the international community to continue to assist developing countries in promoting the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, including through access to medicines, in particular essential medicines, vaccines, diagnostics, medical devices, assistive technologies and other health products that are affordable, safe, effective and of quality, and through financial and technical support, training of personnel and other capacity-building measures, while recognizing that the primary responsibility for respecting, protecting and fulfilling all human rights rests with States, and recognizing also the fundamental importance of the transfer of environmentally sound technologies on favourable terms, including on concessional and preferential terms, as mutually agreed;</p>
        </content>
      </paragraph>
      <paragraph eId="para_87" class="SingleTxtG">
        <num>8.</num>
        <content eId="para_87__content">
          <p xml:space="preserve"> 	<span class="italic">Recognizes</span> the innovative funding mechanisms and arrangements that contribute to the availability of vaccines and medicines in developing countries, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Gavi Alliance, Unitaid, the Access to COVID‑19 Tools (ACT) Accelerator initiative and the Health Technology Access Programme (HTAP), especially for those living in poverty, children and other persons in vulnerable situations, and calls upon all States, United Nations agencies, funds and programmes, in particular the World Health Organization, and relevant intergovernmental organizations, within their respective mandates, and encourages relevant stakeholders, including companies involved in the research and development, manufacture, importing, distribution and supply of pharmaceuticals, while safeguarding public health from undue influence by any form of real, perceived or potential conflict of interest, to further collaborate to enable equitable access to quality, safe and effective medicines and vaccines that are affordable to all, including those living in poverty, children and other persons in vulnerable situations;</p>
        </content>
      </paragraph>
      <paragraph eId="para_95" class="SingleTxtG">
        <num>9.</num>
        <content eId="para_95__content">
          <p xml:space="preserve"> 	<span class="italic">Encourages</span> engagement among Governments, international organizations, non‑governmental organizations, academic and research institutions, philanthropic foundations and the private sector and greater policy coherence and coordinated actions through whole-of-government, whole-of-society and Health in All Policies approaches to find solutions to health challenges, such as the need for public health-driven research and development, improved existing and alternative frameworks to adequately reward innovation, pricing and affordability of health products, and leveraging innovative technologies, including digital technologies, and solutions for health;</p>
        </content>
      </paragraph>
      <paragraph eId="para_104" class="SingleTxtG">
        <num>10.</num>
        <content eId="para_104__content">
          <p xml:space="preserve"> 	<span class="italic">Encourages</span> States, in cooperation with other stakeholders, to redouble efforts to achieve a continuous supply of quality, safe, effective and affordable health products through research and development that meets public health needs, for the efficient application and management of intellectual property standards, to carry out evidence-based selection of health products and to seek fair and affordable pricing, to adopt good procurement and supply chain management and to promote appropriate prescribing, dispensing and rational use of health products;</p>
        </content>
      </paragraph>
      <paragraph eId="para_114" class="SingleTxtG">
        <num>11.</num>
        <content eId="para_114__content">
          <p xml:space="preserve"> 	<span class="italic">Recognizes</span> the importance of adequately training the health workforce, including community health workers, and of improving health literacy in order to achieve the highest attainable standard of physical and mental health and strengthen equitable and universal health coverage;</p>
        </content>
      </paragraph>
      <paragraph eId="para_125" class="SingleTxtG">
        <num>12.</num>
        <content eId="para_125__content">
          <p xml:space="preserve"> 	<span class="italic">Urges</span> all States, United Nations agencies, funds and programmes, and relevant intergovernmental organizations, especially the World Health Organization, within their respective mandates, and encourages non‑governmental organizations and relevant stakeholders, including pharmaceutical companies, to promote innovative research and development to address health needs in developing countries, including access to safe, effective, quality and affordable medicines and vaccines, in particular with regard to diseases disproportionately affecting developing countries, and the challenges arising from the growing burden of non‑communicable diseases, while taking into account the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property of the World Health Organization;	</p>
        </content>
      </paragraph>
      <paragraph eId="para_137" class="SingleTxtG">
        <num>13.</num>
        <content eId="para_137__content">
          <p xml:space="preserve"> 	<span class="italic">Requests</span> the Office of the United Nations High Commissioner for Human Rights to enhance its work, within its mandate, in the field of the human rights dimension of access to medicines and vaccines, in the context of the right of everyone to the highest attainable standard of physical and mental health as guaranteed by the International Covenant on Economic, Social and Cultural Rights;</p>
        </content>
      </paragraph>
      <paragraph eId="para_150" class="SingleTxtG">
        <num>14.</num>
        <content eId="para_150__content">
          <p xml:space="preserve"> 	<span class="italic">Invites</span> the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, while considering the many ways towards the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health, to continue to focus on the human rights dimension of timely, equitable and unhindered access to safe, affordable, effective and quality medicines, vaccines and other health products globally during current and future health emergencies when discharging his or her duties, in accordance with the mandate;</p>
        </content>
      </paragraph>
      <paragraph eId="para_164" class="SingleTxtG">
        <num>15.</num>
        <content eId="para_164__content">
          <p xml:space="preserve"> 	<span class="italic">Invites </span>States and all stakeholders, including relevant United Nations bodies, agencies, funds and programmes, treaty bodies, special procedure mandate holders, national human rights institutions, civil society and the private sector, to promote policy coherence in the areas of human rights, public health, intellectual property and international trade and investment when considering access to medicines and vaccines;</p>
        </content>
      </paragraph>
      <paragraph eId="para_179" class="SingleTxtG">
        <num>16.</num>
        <content eId="para_179__content">
          <p xml:space="preserve"> 	<span class="italic">Requests</span> the Office of the High Commissioner to continue its work, within its mandate, to provide technical assistance to States throughout the next three years on the human rights dimension of access to medicines and vaccines in the context of the right of everyone to the highest attainable standard of physical and mental health, including with regard to barriers to access for vulnerable segments of the population and for developing countries, in particular least developed States, landlocked States and small island developing States, and with regard to models, mechanisms and arrangements of international and regional cooperation, and to present an analytical study on protection gaps of vulnerable segments of the population to the Human Rights Council at its sixty-second session, with a view to presenting to the Council, at its sixty-eighth session, a comprehensive report, including on the measures necessary to bridge protection gaps to ensure the accessibility and availability of medicines, vaccines and other health products, and to prepare the above submissions in an accessible and easy-to-read format;</p>
        </content>
      </paragraph>
      <paragraph eId="para_195" class="SingleTxtG">
        <num>17.</num>
        <content eId="para_195__content">
          <p xml:space="preserve"> 	<span class="italic">Also requests</span> the Office of the High Commissioner to seek input from experts from diverse geographic regions, including from States and local governments, relevant intergovernmental organizations, United Nations agencies, funds and programmes, relevant special procedures of the Human Rights Council, the treaty bodies, national human rights institutions and civil society representatives, including relevant non‑governmental organizations, in the preparation of the above-mentioned study and report;</p>
        </content>
      </paragraph>
      <paragraph eId="para_212" class="SingleTxtG">
        <num>18.</num>
        <content eId="para_212__content">
          <p xml:space="preserve"> 	<span class="italic">Calls upon</span> the Office of the High Commissioner to continue its work and set its priorities on economic, social and cultural rights, taking into consideration relevant resolutions and decisions of the Human Rights Council, with due regard to the fulfilment of the obligations of international cooperation as essential requirements for the realization of these rights.</p>
        </content>
      </paragraph>
    </mainBody>
    <conclusions eId="conclusions">
      <p>
        <event refersTo="#adoption">
          <location title="31st" refersTo="#adoptionMeeting">31st meeting</location>
          <eol />
          <docDate date="2025-07-07" refersTo="#adoptionDate">7 July 2025</docDate>
        </event>
      </p>
      <p>
        <vote by="#humanRightsCouncil" as="#author">
          <outcome refersTo="#adoptedRecordedVote">[Adopted by a recorded vote of <quantity normalized="32" refersTo="#inFavour">32</quantity> to <quantity normalized="0" refersTo="#against">0</quantity>, with <quantity normalized="15" refersTo="#abstaining">15</quantity> abstentions. The voting was as follows:<outcome refersTo="inFavour">In favour:<eol /><organization refersTo="memberState">Algeria, Bangladesh, Benin, Bolivia (Plurinational State of), Brazil, Burundi, Chile, China, Colombia, Costa Rica, Côte d’Ivoire, Cuba, Democratic Republic of the Congo, Dominican Republic, Ethiopia, Gambia, Ghana, Indonesia, Kenya, Kuwait, Kyrgyzstan, Malawi, Maldives, Marshall Islands, Mexico, Morocco, Qatar, Republic of Korea, South Africa, Sudan, Thailand, Viet Nam</organization></outcome><outcome refersTo="against">Against:<eol /><organization refersTo="memberState"></organization></outcome><outcome refersTo="abstaining">Abstaining:<eol /><organization refersTo="memberState">Albania, Belgium, Bulgaria, Cyprus, Czechia, France, Georgia, Germany, Iceland, Japan, Netherlands (Kingdom of the), North Macedonia, Romania, Spain, Switzerland]</organization></outcome></outcome>
        </vote>
      </p>
    </conclusions>
  </statement>
</akomaNtoso>